{
  "PMC": "6275943",
  "DOI": "10.2478/s11658-014-0204-6",
  "PMID": "25141978",
  "PMCID": "PMC6275943",
  "title": "The potential role of O-GlcNAc modification in cancer epigenetics.",
  "year": 2014,
  "source_url": "https://europepmc.org/article/PMC/PMC6275943",
  "source": "MED",
  "abstract_text": "There is no doubt that cancer is not only a genetic disease but that it can also occur due to epigenetic abnormalities. Diet and environmental factors can alter the scope of epigenetic regulation. The results of recent studies suggest that O-GlcNAcylation, which involves the addition of N-acetylglucosamine on the serine or threonine residues of proteins, may play a key role in the regulation of the epigenome in response to the metabolic status of the cell. Two enzymes are responsible for cyclic O-GlcNAcylation: O-GlcNAc transferase (OGT), which catalyzes the addition of the GlcNAc moiety to target proteins; and O-GlcNAcase (OGA), which removes the sugar moiety from proteins. Aberrant expression of O-GlcNAc cycling enzymes, especially OGT, has been found in all studied human cancers. OGT can link the cellular metabolic state and the epigenetic status of cancer cells by interacting with and modifying many epigenetic factors, such as HCF-1, TET, mSin3A, HDAC, and BAP1. A growing body of evidence from animal model systems also suggests an important role for OGT in polycomb-dependent repression of genes activity. Moreover, O-GlcNAcylation may be a part of the histone code: O-GlcNAc residues are found on all core histones.",
  "full_text": "Cell Mol Biol Lett Cell. Mol. Biol. Lett Cellular & Molecular Biology Letters 1425-8153 1689-1392 Versita Heidelberg 6275943 25141978 204 10.2478/s11658-014-0204-6 Review The potential role of O-GlcNAc modification in cancer epigenetics Forma Ewa Jóźwiak Paweł Bryś Magdalena Krześlak Anna 48-42-6354371 48-42-6354484 krzeslak@biol.uni.lodz.pl grid.10789.37 0000000097302769 Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Łódź, Pomorska 141/143, 90-237 Łódź, Poland 20 8 2014 9 2014 19 3 438 460 12 3 2014 1 8 2014 © Versita Warsaw and Springer-Verlag Wien 2014 There is no doubt that cancer is not only a genetic disease but that it can also occur due to epigenetic abnormalities. Diet and environmental factors can alter the scope of epigenetic regulation. The results of recent studies suggest that O-GlcNAcylation, which involves the addition of N-acetylglucosamine on the serine or threonine residues of proteins, may play a key role in the regulation of the epigenome in response to the metabolic status of the cell. Two enzymes are responsible for cyclic O-GlcNAcylation: O-GlcNAc transferase (OGT), which catalyzes the addition of the GlcNAc moiety to target proteins; and O-GlcNAcase (OGA), which removes the sugar moiety from proteins. Aberrant expression of O-GlcNAc cycling enzymes, especially OGT, has been found in all studied human cancers. OGT can link the cellular metabolic state and the epigenetic status of cancer cells by interacting with and modifying many epigenetic factors, such as HCF-1, TET, mSin3A, HDAC, and BAP1. A growing body of evidence from animal model systems also suggests an important role for OGT in polycomb-dependent repression of genes activity. Moreover, O-GlcNAcylation may be a part of the histone code: O-GlcNAc residues are found on all core histones. Keywords O-GlcNAcylation Cancer O-GlcNAc transferase Histone modifications Host cell factor 1 Ten-eleven translocation Polycomb issue-copyright-statement © Versita Warsaw and Springer-Verlag Wien 2014 Abbreviations used 5-hmC 5-hydoxymethylcytosine BAP1 BRCA1-associated protein 1 BMI-1 B lymphoma Mo-MLV insertion region 1 homolog BMP bone morphogenic protein EMT epithelial-mesenchymal transition FGF fibroblast growth factor GFAT glutamine:fructose-6-phosphate amidotransferase H3K4me3 trimethylation of histone H3 at lysine 4 HBP hexosamine biosynthetic pathway HCF-1 host cell factor 1 HPC human polycomb HPH human polyhomeotic MLL myeloid/lymphoid or mixed-lineage leukemia OGA β-N-acetylglucosaminidase OGT O-linked N-acetylglucosamine transferase PcG polycomb group protein pRb the product of the retinoblastoma gene PRC polycomb repression complex RING 1A really interesting new gene 1A TET ten eleven translocation THAP Thanatosassociated protein TPA 12- O -tetradecanoylphorbol 13-acetate ubH2B ubiquitylated histone H2B References 1. Goldberg AD Allis CD Bernstein E Epigenetics: A landscape takes shape Cell 2007 128 635 638 17320500 2. Ducasse M Brown MA Epigenetic aberrations and cancer Mol. Cancer 2006 5 60 17092350 3. Sharma S Kelly TK Jones PA Epigenetics in cancer Carcinogenesis 2010 31 27 36 19752007 4. Ellis L Atadja PW Johnstone RW Epigenetics in cancer: targeting chromatin modifications Mol. Cancer Ther. 2009 8 1409 1420 19509247 5. Lim U Song MA Dietary and lifestyle factors of DNA methylation Methods Mol. Biol. 2012 863 359 376 22359306 6. Herceg Z Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors Mutagenesis 2007 22 91 103 17284773 7. Hardy TM Tollefsbol TO Epigenetic diet: impact on the epigenome and cancer Epigenomics 2011 3 503 518 22022340 8. Jiménez-Chillarón JC Díaz R Martínez D Pentinat T Ramón-Krauel M Ribó S Plösch T The role of nutrition on epigenetic modifications and their implications on health Biochimie 2012 94 2242 2263 22771843 9. Roberts DL Dive C Renehan AG Biological mechanisms linking obesity and cancer risk: new perspectives Annu. Rev. Med. 2010 61 301 316 19824817 10. Simon D Balkau B Diabetes mellitus, hyperglycaemia and cancer Diabetes Metab. 2010 36 182 191 20554237 11. Bensinger SJ Christofk HR New aspects of the Warburg effect in cancer cell biology Semin. Cell Dev. Biol. 2012 23 352 361 22406683 12. Dang CV Links between metabolism and cancer Genes Dev. 2012 26 877 890 22549953 13. Krzeslak A Wojcik-Krowiranda K Forma E Jozwiak P Romanowicz H Bienkiewicz A Brys M Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers Pathol. Oncol. Res. 2012 18 721 728 22270867 14. Jóźwiak P Krześlak A Pomorski L Lipińska A Expression of hypoxia-related glucose transporters GLUT1 and GLUT3 in benign, malignant and non-neoplastic thyroid lesions Mol. Med. Rep. 2012 6 601 606 22752218 15. Jóźwiak P Lipińska A The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors Post. Hig. Med. Dosw. 2012 66 165 174 16. Szablewski L Expression of glucose transporters in cancers Biochim. Biophys. Acta 2013 1835 164 169 23266512 17. Butkinaree C Park K Hart GW O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress Biochim. Biophys. Acta 2010 1800 96 106 19647786 18. Slawson C Copeland RJ Hart GW O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends Biochem. Sci. 2010 35 547 555 20466550 19. Hanover JA Krause MW Love DC The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine Biochim. Biophys. Acta 2010 1800 80 95 19647043 20. Slawson C Hart GW O-GlcNAc signalling: implications for cancer cell biology Nat. Rev. Cancer 2011 11 678 684 21850036 21. Vocadlo DJ O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation Curr. Opin. Chem. Biol. 2012 16 488 497 23146438 22. Bullen JW Balsbaugh JL Chanda D Shabanowitz J Hunt DF Neumann D Hart GW Cross-talk between two essential nutrientsensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK) J. Biol. Chem. 2014 289 10592 606 24563466 23. Xu Q Yang C Du Y Chen Y Liu H Deng M Zhang H Zhang L Liu T Liu Q Wang L Lou Z Pei H AMPK regulates histone H2B O-GlcNAcylation Nucleic Acids Res. 2014 24. Hu P Shimoji S Hart GW Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation FEBS Lett. 2010 584 2526 2538 20417205 25. Özcan S Andrali SS Cantrell JE Modulation of transcription factor function by O-GlcNAc modification Biochim. Biophys. Acta 2010 1799 353 364 20202486 26. Ruan HB Singh JP Li MD Wu J Yang X Cracking the O-GlcNAc code in metabolism Trends Endocrinol. Metab. 2013 24 301 309 23647930 27. Hart GW Slawson C Ramirez-Correa G Lagerlof O Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease Annu. Rev. Biochem. 2011 80 825 858 21391816 28. Onodera Y Nam JM Bissell MJ Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways J. Clin. Invest. 2013 29. Li Z Yi W Regulation of cancer metabolism by O-GlcNAcylation Glycoconj. J. 2013 30. Mi W Gu Y Han C Liu H Fan Q Zhang X Cong Q Yu W O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy Biochim. Biophys. Acta 2011 1812 514 519 21255644 31. Lynch TP Ferrer CM Jackson SR Shahriari KS Vosseller K Reginato MJ Crtical role of O-linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis J. Biol. Chem. 2012 287 11070 11081 22275356 32. Caldwell SA Jackson SR Shahriari KS Lynch TP Sethi G Walker S Vosseller K Reginato MJ Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1 Oncogene 2010 29 2831 2842 20190804 33. Gu Y Mi W Ge Y Liu H Fan Q Han C Yang J Han F Lu X Yu W GlcNAcylation plays an essential role in breast cancer metastasis Cancer Res. 2010 70 6344 6351 20610629 34. Yehezkel G Cohen L Kliger A Manor E Khalaila I O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) in primary and metastatic colorectal cancer clones and effect of N-acetyl-β-D-glucosaminidase silencing on cell phenotype and transcriptome J. Biol. Chem. 2012 287 28755 28769 22730328 35. Phueaouan T Chaiyawat P Netsirisawan P Chokchaichamnankit D Punyarit P Srisomsap C Svasti J Champattanachai V Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer Oncol. Rep. 2013 30 2929 2936 24126823 36. Zhu Q Zhou L Yang Z Lai M Xie H Wu L Xing C Zhang F Zheng S O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation Med. Oncol. 2012 29 985 993 21461968 37. Ma Z Vosseller K O-GlcNAc in cancer biology Amino Acids 2013 45 719 733 23836420 38. Shi Y Tomic J Wen F Shaha S Bahlo A Harrison R Dennis JW Williams R Gross BJ Walker S Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia Leukemia 2010 24 1588 1598 20668475 39. Krześlak A Forma E Bernaciak M Romanowicz H Bryś M Gene expression of O-GlcNAc cycling enzymes in human breast cancers Clin. Exp. Med. 2012 12 61 65 21567137 40. Krześlak A Wójcik-Krowiranda K Forma E Bieńkiewicz A Bryś M Expression of genes encoding for enzymes associated with O-GlcNAcylation in endometrial carcinomas: clinicopathologic correlations Ginekol. Pol. 2012 83 22 26 22384635 41. Rozanski W Krześlak A Forma E Bryś M Blewniewski M Wozniak P Lipinski M Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level Clin. Lab. 2012 58 579 583 22783592 42. Champattanachai V Netsirisawan P Chaiyawat P Phueaouan T Charoenwattanasatien R Chokchaichamnankit D Punyarit P Srisomsap C Svasti J Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer Proteomics 2013 13 2088 2099 23576270 43. Fardini Y Dehennaut V Lefebvre T Issad T O-GlcNAcylation: a new cancer hallmark? Front. Endocrinol. 2013 4 99 44. Wang, Z., Udeshi, N.D., Slawson, C., Compton, P.D., Sakabe, K., Cheung, W.D., Shabanowitz, J., Hunt, D.F. and Hart, G.W. Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci. Signal. 3 (2010) ra2. DOI: 10.1126/scisignal.2000526. 45. Krześlak A Jóźwiak P Lipińska A Down-regulation of β-N-acetyl-D-glucosaminidase increases Akt1 activity in thyroid anaplastic cancer cells Oncol. Rep. 2011 26 743 749 21637923 46. Huang X Pan Q Sun D Chen W Shen A Huang M Ding J Geng M O-GlcNAcylation of cofilin promotes breast cancer cell invasion J. Biol. Chem. 2013 288 36418 36425 24214978 47. Park SY Kim HS Kim NH Ji S Cha SY Kang JG Ota I Shimada K Konishi N Nam HW Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition EMBO J. 2010 29 3787 3796 20959806 48. Thiery JP Acloque H Huang RY Nieto MA Epithelialmesenchymal transitions in development and disease Cell 2009 139 871 890 19945376 49. Zhu W Leber B Andrews DW Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis EMBO J. 2001 20 5999 6007 11689440 50. Jin FZ Yu C Zhao DZ Wu MJ Yang Z A correlation between altered O-GlcNAcylation, migration and with changes in E-cadherin levels in ovarian cancer cells Exp. Cell. Res. 2013 319 1482 1490 23524144 51. Kanwal R Gupta S Epigenetic modifications in cancer Clin. Genet. 2012 81 303 311 22082348 52. Hassler MR Egger G Epigenomics of cancer — emerging new concepts Biochimie 2012 94 2219 2230 22609632 53. Tsai HC Baylin SB Cancer epigenetics: linking basic biology to clinical medicine Cell Res. 2011 21 502 517 21321605 54. Sakabe K Wang Z Hart GW Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code Proc. Natl. Acad. Sci. USA 2010 107 19915 19920 21045127 55. Zhang S Roche K Nasheuer HP Lowndes NF Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated J. Biol. Chem. 2011 286 37483 37495 21896475 56. Fujiki R Hashiba W Sekine H Yokoyama A Chikanishi T Ito S Imai Y Kim J He HH Igarashi K Kanno J Ohtake F Kitagawa H Roeder RG Brown M Kato S GlcNAcylation of histone H2B facilitates its monoubiquitination Nature 2011 480 557 560 22121020 57. Fong JJ Nguyen BL Bridger R Medrano EE Wells L Pan S Sifers RN β-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3 J. Biol. Chem. 2012 287 12195 12203 22371497 58. Gao Z Xu CW Glucose metabolism induces mono-ubiquitination of histone H2B in mammalian cells Biochem. Biophys. Res. Commun. 2011 404 428 433 21130743 59. Urasaki Y Heath L Xu CW Coupling of glucose deprivation with impaired histone H2B monoubiquitination in tumors PLoS One 2012 7 e36775 22615809 60. Shema E Tirosh I Aylon Y Huang J Ye C Moskovits N Raver-Shapira N Minsky N Pirngruber J Tarcic G Hublarova P Moyal L Gana-Weisz M Shiloh Y Yarden Y Johnsen SA Vojtesek B Berger SL Oren M The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression Genes Dev. 2008 22 2664 2676 18832071 61. Chernikova SB Razorenova OV Higgins JP Sishc BJ Nicolau M Dorth JA Chernikova DA Kwok S Brooks JD Bailey SM Game JC Brown JM Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability Cancer Res. 2012 72 2111 2119 22354749 62. Chen Q Chen Y Bian C Fujiki R Yu X TET2 promotes histone O-GlcNAcylation during gene transcription Nature 2013 493 561 564 23222540 63. Deplus R Delatte B Schwinn MK Defrance M Méndez J Murphy N Dawson MA Volkmar M Putmans P Calonne E Shih AH Levine RL Bernard O Mercher T Solary E Urh M Daniels DL Fuks F TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS EMBO J. 2013 32 645 655 23353889 64. Sakabe K Hart GW O-GlcNAc transferase regulates mitotic chromatin dynamics J. Biol. Chem. 2010 285 34460 34468 20805223 65. Baek SH When signaling kinases meet histones and histone modifiers in the nucleus Mol. Cell 2011 42 274 284 21549306 66. Nowak SJ Corces VG Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation Trends Genet. 2004 20 214 220 15041176 67. Choi HS Choi BY Cho YY Mizuno H Kang BS Bode AM Dong Z Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation Cancer Res. 2005 65 5818 5827 15994958 68. Zippo A De Robertis A Serafini R Oliviero S PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation Nat. Cell. Biol. 2007 9 932 944 17643117 69. Chadee DN Hendzel MJ Tylipski CP Allis CD Bazett-Jones DP Wright JA Davie JR Increased Ser-10 phosphorylation of histone H3 in mitogen stimulated and oncogene-transformed mouse fibroblasts J. Biol. Chem. 1999 274 24914 24920 10455166 70. Strelkov IS Davie JR Ser-10 phosphorylation of histone H3 and immediate early gene expression in oncogene-transformed mouse fibroblasts Cancer Res. 2002 62 75 78 11782362 71. Kim HG Lee KW Cho YY Kang NJ Oh SM Bode AM Dong Z Mitogen and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation Cancer Res. 2008 68 2538 2547 18381464 72. Tange S Ito S Senga T Hamaguchi M Phosphorylation of histone H3 at Ser10: its role in cell transformation by v-Src Biochem. Biophys. Res. Commun. 2009 386 588 592 19540193 73. Portella G Passaro C Chieffi P Aurora B: a new prognostic marker and therapeutic target in cancer Curr. Med. Chem. 2011 18 482 496 21143115 74. Murnion ME Adams RR Callister DM Allis CD Earnshaw WC Swedlow JR Chromatin-associated protein phosphatase 1 regulates aurora-B and histone H3 phosphorylation J. Biol. Chem. 2001 276 26656 26665 11350965 75. Wells L Kreppel LK Comer FI Wadzinski BE Hart GW O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits J. Biol. Chem. 2004 279 38466 38470 15247246 76. Slawson C Lakshmanan T Knapp S Hart GW A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin Mol. Biol. Cell 2008 19 4130 4140 18653473 77. Tan EP Caro S Potnis A Lanza C Slawson C O-linked N-acetylglucosamine cycling regulates mitotic spindle organization J. Biol. Chem. 2013 288 27085 27099 23946484 78. Capotosti F Guernier S Lammers F Waridel P Cai Y Jin J Conaway JW Conaway RC Herr W O-GlcNAc transferase catalyzes site-specific proteolysis of HCF-1 Cell 2011 144 376 388 21295698 79. Hanover JA A versatile sugar transferase makes the cut Cell 2011 144 321 322 21295693 80. Coller HA Is cancer a metabolic disease? Am. J. Pathol. 2014 184 4 17 24139946 81. Ruan HB Han X Li MD Singh JP Qian K Azarhoush S Zhao L Bennett AM Samuel VT Wu J Yates JR 3rd Yang X O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability Cell Metab. 2012 16 226 237 22883232 82. Zargar ZU Tyagi S Role of host cell factor-1 in cell cycle regulation Transcription 2012 34 187 192 83. Glinsky GV Berezovska O Glinskii AB Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer J. Clin. Invest. 2005 115 1503 1521 15931389 84. Julien E Herr W Proteolytic processing is necessary to separate an ensure proper cell growth and cytokinesis functions of HCF-1 EMBO J. 2003 22 2360 2369 12743030 85. Julien E Herr W A switch in mitotic histone H4 lysine 20 methylation status is linked to M phase defects upon loss of HCF1 Mol. Cell 2004 14 713 725 15200950 86. Tyagi S Herr W E2F mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferase EMBO J. 2009 28 3185 3195 19763085 87. Wysocka J Myers MP Laherty CD Eisenman RN Herr W Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1 Genes Dev. 2003 17 896 911 12670868 88. Mazars R Gonzalez-de-Peredo A Cayrol C Lavigne AC Vogel JL Ortega N Lacroix C Gautier V Huet G Ray A Monsarrat B Kristie TM Girard JP The THAP-zinc finger protein THAP1 associates with coactivator HCF-1 and O-GlcNAc transferase: a link between DYT6 and DYT3 dystonias J. Biol. Chem. 2010 285 13364 13371 20200153 89. Daou S Mashtalir N Hammond-Martel I Pak H Yu H Sui G Vogel JL Kristie TM Affar el B Crosstalk between OGlcNAcylation and proteolytic cleavage regulates the host cell factor-1 maturation pathway Proc. Natl. Acad. Sci. USA 2011 108 2747 2752 21285374 90. Lazarus MB Jiang J Kapuria V Bhuiyan T Janetzko J Zandberg WF Vocadlo DJ Herr W Walker S HCF-1 is cleaved in the active site of O-GlcNAc transferase Science 2013 342 1235 1239 24311690 91. Reilly PT Wysocka J Herr W Inactivation of the retinoblastoma protein family can bypass the HCF-1 defect in tsBN67 cell proliferation and cytokinesis Mol. Cell. Biol. 2002 22 6767 6778 12215534 92. Wells L Slawson C Hart GW The E2F-1 associated retinoblastomasusceptibility gene product is modified by O-GlcNAc Amino Acids 2011 40 877 883 20680651 93. Murali R Wiesner T Scolyer RA Tumors associated with BAP1 mutations Pathology 2013 45 116 126 23277170 94. Dey A Seshasayee D Noubade R French DM Liu J Chaurushiya MS Kirkpatrick DS Pham VC Lill JR Bakalarski CE Wu J Phu L Katavolos P LaFave LM Abdel-Wahab O Modrusan Z Seshagiri S Dong K Lin Z Balazs M Suriben R Newton K Hymowitz S Garcia-Manero G Martin F Levine RL Dixit V M Loss of the tumor suppressor BAP1 causes myeloid transformation Science 2012 337 1541 1546 22878500 95. Yang X Zhang F Kudlow JE Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression Cell 2002 110 69 80 12150998 96. Cayrol C Lacroix C Mathe C Ecochard V Ceribelli M Loreau E Lazar V Dessen P Mantovani R Aguilar L Girard JP The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes Blood 2007 109 584 594 17003378 97. Macfarlan T Kutney S Altman B Montross R Yu J Chakravarti D Girard JP Human THAP7 is a chromatin-associated, histone tailbinding protein that represses transcription via recruitment of HDAC3 and nuclear hormone receptor corepressor J. Biol. Chem. 2005 280 7346 7358 15561719 98. Roussigne M Cayrol C Clouaire T Amalric F Girard JP THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies Oncogene 2003 22 2432 2442 12717420 99. Zhu CY Li CY Li Y Zhan YQ Li YH Xu CW Xu WX Sun HB Yang XM Cell growth suppression by thanatos-associated protein 11 (THAP11) is mediated by transcriptional downregulation of c-Myc Cell Death Differ. 2009 16 395 405 19008924 100. Dejosez M Krumenacker JS Zitur LJ Passeri M Chu LF Songyang Z Thomson JA Zwaka TP Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells Cell 2008 133 1162 1174 18585351 101. Parker JB Palchaudhuri S Yin H Wei J Chakravarti DA Transcriptional regulatory role of the THAP11-HCF-1 complex in colon cancer cell function Mol. Cell. Biol. 2012 32 1654 1670 22371484 102. Ito S D’Alessio AC Taranova OV Hong K Sowers LC Zhang Y Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification Nature 2010 466 1129 1133 20639862 103. Tahiliani M Koh KP Shen Y Pastor WA Bandukwala H Brudno Y Agarwal S Iyer LM Liu DR Aravind L Rao A Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 Science 2009 324 930 935 19372391 104. Kriaucionis S Heintz N The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain Science 2009 324 929 930 19372393 105. Pfeifer GP Kadam S Jin SG 5-hydroxymethylcytosine and its potential roles in development and cancer Epigenetics Chromatin. 2013 6 10 23634848 106. Lorsbach RB Moore J Mathew S Raimondi SC Mukatira ST Downing JR TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23) Leukemia 2003 17 637 641 12646957 107. Delatte B Fuks F TET proteins: on the frenetic hunt for new cytosine modifications Brief Funct. Genomics 2013 12 191 204 23625996 108. Tan L Shi YG Tet family proteins and 5-hydroxymethylcytosine in development and disease Development 2012 139 1895 1902 22569552 109. Jin SG Jiang Y Qiu R Rauch TA Wang Y Schackert G Krex D Lu Q Pfeifer GP 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutation Cancer Res. 2011 71 7360 7365 22052461 110. Haffner MC Chaux A Meeker AK Esopi DM Gerber J Pellakuru LG Toubaji A Argani P Iacobuzio-Donahue C Nelson WG Netto GJ De Marzo AM Yegnasubramanian S Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers Oncotarget 2011 6 627 637 111. Yang H Liu Y Bai F Zhang JY Ma SH Liu J Xu ZD Zhu HG Ling ZQ Ye D Guan KL Xiong Y Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation Oncogene 2013 6 663 669 112. Kraus TF Globisch D Wagner M Eigenbrod S Widmann D Munzel M Muller M Pfaffeneder T Hackner B Feiden W Schüller U Carell T Kretzschmar HA Low values of 5-hydroxymethylcytosine (5hmC), the “sixth base”, are associated with anaplasia in human brain tumors Int. J. Cancer 2012 6 1577 1590 113. Kudo Y Tateishi K Yamamoto K Yamamoto S Asaoka Y Ijichi H Nagae G Yoshida H Aburatani H Koike K Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation Cancer Sci. 2012 6 670 676 114. Lian CG Xu Y Ceol C Wu F Larson A Dresser K Xu W Tan L Hu Y Zhan Q Lee CW Hu D Lian BQ Kleffel S Yang Y Neiswender J Khorasani AJ Fang R Lezcano C Duncan LM Scolyer RA Thompson JF Kakavand H Houvras Y Zon LI Mihm MC Jr Kaiser UB Schatton T Woda BA Murphy GF Shi YG Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma Cell 2012 6 1135 1146 115. Ito R Katsura S Shimada H Tsuchiya H Hada M Okumura T Sugawara A Yokoyama A TET3-OGT interaction increases the stability and the presence of OGT in chromatin Genes Cells 2014 19 52 65 24304661 116. Wu H D’Alessio AC Ito S Xia K Wang Z Cui K Zhao K Sun YE Zhang Y Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells Nature 2011 473 389 393 21451524 117. Williams K Christensen J Pedersen MT Johansen JV Cloos PA Rappsilber J Helin K TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity Nature 2011 473 343 348 21490601 118. Shi FT Kim H Lu W He Q Liu D Goodell MA Wan M Songyang Z Ten-eleven translocation 1 (Tet1) is regulated by O-linked N-acetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells J. Biol. Chem. 2013 288 20776 20784 23729667 119. Yang Q Wu K Ji M Jin W He N Shi B Hou P Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients J. Biomed. Nanotechnol. 2013 9 1607 1616 23980508 120. Fu HL Ma Y Lu LG Hou P Li BJ Jin WL Cui DX TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer J. Biomed. Nanotechnol. 2014 10 1217 1230 24804542 121. Hsu CH Peng KL Kang ML Chen YR Yang YC Tsai CH Chu CS Jeng YM Chen YT Lin FM Huang HD Lu YY Teng YC Lin ST Lin RK Tang FM Lee SB Hsu HM Yu JC Hsiao PW Juan LJ TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases Cell Rep. 2012 2 568 579 22999938 122. Gambetta MC Oktaba K Müller J Essential role of the glycosyltransferase sxc/Ogt in polycomb repression Science 2009 325 93 96 19478141 123. Sinclair DA Syrzycka M Macauley MS Rastgardani T Komljenovic I Vocadlo DJ Brock HW Honda BM Drosophila O-GlcNAc transferase (OGT) is encoded by the Polycomb group (PcG) gene, super sex combs (sxc) Proc. Natl. Acad. Sci. USA 2009 106 13427 13432 19666537 124. Love DC Krause MW Hanover JA O-GlcNAc cycling: emerging roles in development and epigenetics Semin. Cell. Dev. Biol. 2010 21 646 654 20488252 125. Hanover JA Krause MW Love DC Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation Nat. Rev. Mol. Cell. Biol. 2012 13 312 321 22522719 126. Leeb M Wutz A Establishment of epigenetic patterns in development Chromosoma 2012 121 251 262 22427185 127. Richly H Aloia L Di Croce L Roles of the Polycomb group proteins in stem cells and cancer Cell. Death Dis. 2011 2 e204 21881606 128. Morey L Helin K Polycomb group protein-mediated repression of transcription Trends Biochem. Sci. 2010 35 323 332 20346678 129. Kuzmichev A Nishioka K Erdjument-Bromage H Tempst P Reinberg D Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein Genes Dev. 2002 16 2893 2905 12435631 130. Francis NJ Kingston RE Woodcock CL Chromatin compaction by a polycomb group protein complex Science 2004 306 1574 1577 15567868 131. Tsang DP Cheng AS Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2 J. Gastroenterol. Hepatol. 2011 26 19 27 21175789 132. Myers SA Panning B Burlingame AL Polycomb repressive complex 2 is necessary for the normal site-specific O-GlcNAc distribution in mouse embryonic stem cells Proc. Natl. Acad. Sci. USA 2011 108 9490 9495 21606357 133. Chu CS Lo PW Yeh YH Hsu PH Peng SH Teng YC Kang ML Wong CH Juan LJ O-GlcNAcylation regulates EZH2 protein stability and function Proc. Natl. Acad. Sci. USA. 2014 111 1355 1360 24474760",
  "plain_text": "There is no doubt that cancer is not only a genetic disease but that it can also occur due to epigenetic abnormalities. Diet and environmental factors can alter the scope of epigenetic regulation. The results of recent studies suggest that O-GlcNAcylation, which involves the addition of N-acetylglucosamine on the serine or threonine residues of proteins, may play a key role in the regulation of the epigenome in response to the metabolic status of the cell. Two enzymes are responsible for cyclic O-GlcNAcylation: O-GlcNAc transferase (OGT), which catalyzes the addition of the GlcNAc moiety to target proteins; and O-GlcNAcase (OGA), which removes the sugar moiety from proteins. Aberrant expression of O-GlcNAc cycling enzymes, especially OGT, has been found in all studied human cancers. OGT can link the cellular metabolic state and the epigenetic status of cancer cells by interacting with and modifying many epigenetic factors, such as HCF-1, TET, mSin3A, HDAC, and BAP1. A growing body of evidence from animal model systems also suggests an important role for OGT in polycomb-dependent repression of genes activity. Moreover, O-GlcNAcylation may be a part of the histone code: O-GlcNAc residues are found on all core histones."
}
